Drugs / Briplatin
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00209716 | Dec 2003 → Oct 2009 | esophageal cancer | Hokkaido Gastrointestinal Cancer Study Group | Completed | No outcome recorded |
| Phase 1/2 | NCT00209690 | Oct 2003 → Dec 2009 | esophageal cancer | Hokkaido Gastrointestinal Cancer Study Group | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Briplatin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00209716 ↗ |
| Route | Intravenous | “15 mg/m2, IV (in the vein)” NCT00209690 ↗ |